-
Good news! The ACR/ARP highlights are now available in Chinese
and Japanese
languages
http://rheumahighlights.com Get the most out of #ACR19!#rheumahighlights#rheumatology -
#tbt#ACR19 "Update in Myositis" session with tips on how to use the new classification criteria I honestly find them difficult and only reference in marginal cases Excellent tables from the presentation, though - great reference for antibodies and presentations!@RheumNowpic.twitter.com/SyzhLZHtcI
-
#ACR2019#acr19 new Guidelines OA:
exercise (aerobic/streng/neuroM/aquatic
)


weigth

tai chi
TENS
(no evidence)
topical/oral NDSAIDs/intraarticular GCs
intraarticular HyA (hip)
glucosamine and/or chondroitin
(Look slides 
) pic.twitter.com/Y76IECqkPJ
-
#tbt#ACR19 - Update in Myositis: Don't forget about toxin induced myopathy! Important mimickers related to treatment we give! 1. Steroid: myopathy w/o inflammation 2. Colchicine: vacuolar myopathy 3. Anti-malarial: vacuolar degeneration P.S. This might be good boards prep... pic.twitter.com/m48UkZlGP3
-
Presenting our poster "Antisynthetase Syndromes: Correlation of IIFA Patterns with Diagnosis Criteria Fulfillment" at
#ACR19 in Atlanta. Many thanks to@fmguanarteme,@MdicosLasPalmas and@SEReumatologia for contributing to this project and its presentation at this meeting.pic.twitter.com/jtIa7cApl9
-
Multiple SS-clinical trial results presented at
#ACR19. The challenge to identify responders remains! Lots of interest for our abatacept follow-up data (week 48) presented by Jolien! pic.twitter.com/ayhnCLeiWs
-
Can the happiest subspecialists experience burnout?
Now back from #ACR19, I am rekindled with a new spark and inspiration thanks to each and every one of you!
Please read my article for @RheumNow on burnout in rheumatology: http://bit.ly/32OXCkb -
Retrospective cohort study of 154 RA patients undergoing 244 major surgeries in shows that perioperative use of DMARDs (39%) or biologics (13%) was not associated with 30-day odds of post-operative infection
#ACR19 Abst #1805 http://bit.ly/34rmyie -
-
Excited to share this
@CreakyJoints report of the big#ACR19 takeaways for patients, with lots of help from@rheum_cat@psufka@EBRheum@HealioRheum@RheumNow & others. Too much to pack into just one resource, so we have 6 wrap-up stories this year!https://creakyjoints.org/education/acr-2019-research/ … -
We’ve got another special Hot Topics episode available on the podcast! Join our host Dr. Hausmann, along with Dr. Ali Duarte Garcia and Dr. Suleman Bhana, as they discuss studies featured in
#ACR19 press conferences. https://acr.tw/32Na5F8 pic.twitter.com/1yVFUL5xX0
-
Are you looking
for a visual summary
of the main #clinicaltrials (and their#targets
& #outcomes) for the#treatment
of systemic #lupus presented at#ACR19?#SLE
Well...here it is!pic.twitter.com/kx1EE3zCXq
-
I missed this one during
#ACR19 (found via@RheumNow's weekly roundup): Abstract L19: Early study, but BAFF inhibitor Ianalumab met its primary endpoint in primary Sjogren's.https://acrabstracts.org/abstract/ianalumab-vay736-a-dual-mode-of-action-biologic-combining-baff-receptor-inhibition-with-b-cell-depletion-for-treatment-of-primary-sjogrens-syndrome-results-of-an-international-randomized/ … -
Management of GCA Guidelines from
#ACR19 (FIXED!): The presenter went quickly by the slide on methotrexate & the slide deck was not available during the presentation. Small update now that slides are available, MTX recs included: "[MTX] can be considered as initial treatment" pic.twitter.com/Cm7jBPeGZz
-
Rheumatic irAEs can: - be severe - be related to oncological response - come on anytime after immunotherapy initiation - persist long after immunotherapy cessation Data from
#ACR19@RheumNow: http://acr19.rheumnow.com/news/rheumatic-immune-related-adverse-events-not-just-another-irae …@cappelliMD@Richter_MD@UmaThanaMD@CCalabreseDO@LCalabreseDO -
I wrote about being a first time patient at
@ACRheum#ACR19 . What an amazing experience, I WILL go again! Thank you@Arthritis_ARC for sponsoring me! Thank you@steveston_gal for being my mentor. Also thanks to those who came to see me speak!http://bit.ly/37hHwmD -
My Utilization management presentation at
#ACR19 was picked up by http://AJMC.com . Check it out.@CSROAdvocacy@ATAPAdvocates How Prior Authorization, Step Therapy Result in Medication Discontinuation and Worse Outcomes https://www.ajmc.com/conferences/acr-2019/how-prior-authorization-step-therapy-result-in-medication-discontinuation-and-worse-outcomes- … via@AJMC_Journal -
Asymptomatic sacroiliitis was observed in about 15% of young IBD pts. Entero MRI may be helpful for early inflammatory changes in IBD pts. abst #1174
#ACR19@RheumNowhttp://ow.ly/v4r350x78Lx -
Thanks to the AF patients who shared their voice and influenced the new ACR/AF OA Treatment Guidelines.
@ArthritisFdn#ACR19 pic.twitter.com/fKgN3mmLwH
-
ACR/AF OA Treatment Guidelines include strong recommendation for exercise.
@ArthritisFdn#ACR19. pic.twitter.com/VVBMXTg1XP
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.